A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : UKU / Udvalg for Kliniske Undersogelser

[Related PubMed/MEDLINE]
Total Number of Papers: 56
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   UKU  (>> Co-occurring Abbreviation)
Long Form:   Udvalg for Kliniske Undersogelser
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Sexual dysfunction in patients with schizophrenia and schizoaffective disorder and its association with adherence to antipsychotic medication. MARS, PRSexDQ
2018 Effect of integrated yoga on anti-psychotic induced side effects and cognitive functions in patients suffering from schizophrenia. IY, SAS
2018 Effect of Olanzapine on Clinical and Polysomnography Profiles in Patients with Schizophrenia. BPRS, NREM, PANSS, REM, SE, TST
2018 Side effect burden of antipsychotic drugs in real life - Impact of gender and polypharmacy. ---
2018 Subjective well-being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new-generation antipsychotic medication. DAI, GAF, PANSS
2017 A Comparative Study of Short Term Efficacy of Aripiprazole and Risperidone in Schizophrenia. AIMS, MINI, PANSS, SAS
2017 A Prospective Study of Adverse Drug Reactions in Patients with Bipolar Disorder in Psychiatry Outpatient Department of a Tertiary Care Hospital. ADRs, AIMS
2017 Relationship Between Daily Dose, Serum Concentration, and Clinical Response to Quetiapine in Children and Adolescents with Psychotic and Mood Disorders. ADRs, CGI-I, TDM, TR
2017 Reliability and Validity of the Short Version of Udvalg for Kliniske Undersogelser in Antipsychotic Treatment. CGI-S, LGM, PSP, SEM
10  2017 Sensory Processing Disorders are Associated with Duration of Current Episode and Severity of Side Effects. AASP, BD, MDD, SPD
11  2016 Chinese version of the Psychotropic-related Sexual Dysfunction Questionnaire (PRSexDQ -SALSEX): Validity and reliability for schizophrenic patients taking antipsychotics. CGI, PANSS
12  2016 Quality of life and functioning in first-episode psychosis Chinese patients with different antipsychotic medications. BARS, MCS, SF-12, SOFAS
13  2016 Quality of Life and Hormonal, Biochemical, and Anthropometric Profile Between Olanzapine and Risperidone Users. ---
14  2015 Comparative study of sexual dysfunction and serum prolactin level associated with olanzapine, risperidone, and clozapine in patients with remitted schizophrenia. ---
15  2015 Side effects related to potentially inappropriate medications in elderly psychiatric patients under everyday pharmacotherapy. PIM, TDM
16  2015 The effects of high-frequency repetitive transcranial magnetic stimulation (rTMS) on negative symptoms of schizophrenia and the follow-up study. CGI, CGI-S, DLPFC, PANSS, rTMS, SANS
17  2014 Quality of life in patients with schizophrenia: the impact of socio-economic factors and adverse effects of atypical antipsychotics drugs. QOL
18  2013 Randomized trial of clozapine vs. risperidone in treatment-naive first-episode schizophrenia: results after one year. LOCF
19  2012 No association between hormonal abnormality and sexual dysfunction in Japanese schizophrenia patients treated with antipsychotics. ---
20  2012 [Quality of life in patients with schizophrenia: a study of 100 cases]. BP, GAF, GH, MH, PANSS, PF, QOL, SF, VT
21  2011 Actigraphic monitoring of activity and rest in schizophrenic patients treated with olanzapine or risperidone. AIS, BARS, CDSS, ESS, PANSS
22  2011 Aripiprazole augmentation in patients with resistant obsessive compulsive disorder: a pilot study. CGI-S, OCD, SSRI, Y-BOCS
23  2011 Assessing a therapeutic exchange protocol for second-generation antidepressants: clinical results. ---
24  2011 Estimation of a multiattribute utility function for the Spanish version of the TooL questionnaire. CGIS, EQ-5D, HRQoL, MADRS, MAUF, PANSS, SF-6D, TTO, VAS, YMRS
25  2011 Multisite, open-label, prospective trial of lamotrigine for geriatric bipolar depression: a preliminary report. CGI-BP, HAM-D, MADRS, WHO-DAS II
26  2010 Clinical response to risperidone in relation to plasma drug concentrations in acutely exacerbated schizophrenic patients. BPRS
27  2010 Sexual dysfunction in Japanese patients with schizophrenia treated with antipsychotics. ---
28  2008 Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach. CAFEPS, CGI, DAS, GAF, PANSS
29  2008 Reliability and validity of the Korean version of UKU-SERS-Pat in patients with bipolar disorder. BD
30  2007 Comparison of clozapine-amisulpride and clozapine-quetiapine combinations for patients with schizophrenia who are partially responsive to clozapine: a single-blind randomized study. BPRS, CGI, SANS, SAS
31  2007 Quetiapine in combination with citalopram in patients with unipolar psychotic depression. AEs, BPRS, CGI, SAS
32  2007 Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia. DAI, PANSS
33  2007 The "Seroquel" Outcomes Study (SOS): Efficacy and tolerability of quetiapine in a long-term, naturalistic study of patients with schizophrenia. BPRS, CGI, SAS, SOS
34  2006 A comparative efficacy and safety study of long-acting risperidone injection and risperidone oral tablets among hospitalized patients: 12-week randomized, single-blind study. PANSS, RLAI
35  2006 An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia. PANSS
36  2006 Gender differences in efficacy and sexual function in long-term trazodone treatment (preliminary results). CGI-S
37  2005 A new atypical antipsychotic: quetiapine-induced sexual dysfunctions. ASEX, PRL, SDs
38  2005 Evaluation of risperidone in the treatment of behavioral and psychological symptoms and sleep disturbances associated with dementia. BPSD, EPS, NPI
39  2005 Somatic symptoms of depression in elderly patients with medical comorbidities. ---
40  2005 [Adverse effects of antipsychotics and quality of life]. QLS
41  2004 A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning. ASFQ
42  2004 Correlates of anticholinergic activity in patients with dementia and psychosis treated with risperidone or olanzapine. NPI
43  2004 Efficacy and tolerability of olanzapine in patients with schizophrenia in lithuania: A 13-week, multicenter, open-label, nonrandomized study. AEs, BPRS, CGI-I, CGI-S, PANSS, PGI-I
44  2003 Histamine H1-receptor antagonists, promethazine and homochlorcyclizine, increase the steady-state plasma concentrations of haloperidol and reduced haloperidol. BPRS
45  2003 Olanzapine, risperidone and haloperidol in the treatment of adolescent patients with schizophrenia. PANSS
46  2003 Safety and efficacy of switching psychiatric patients from a delayed-release to an extended-release formulation of divalproex sodium. DR, ER, PANSS
47  2002 Attitudes toward antipsychotics among outpatient clinic attendees with schizophrenia. DAI
48  2002 Effect of fluoxetine and imipramine on the pharmacokinetics and tolerability of the antipsychotic quetiapine. ---
49  2002 Risperidone in the treatment of mania: efficacy and safety results from a large, multicentre, open study in Spain. CGI, HAM-D, PANSS, YMRS
50  2001 Effect on sexual function of long-term treatment with selective serotonin reuptake inhibitors in depressed patients treated in primary care. ---
51  2001 Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features. MADRS
52  2001 Role of risperidone in bipolar II: an open 6-month study. CGI-BD, YMRS
53  2001 Zuclopenthixol treatment of behavioral disturbances in mentally retarded children and adolescents: an open-label study. CBP-NSA
54  1999 Effects of itraconazole on the steady-state plasma concentrations of bromperidol and reduced bromperidol in schizophrenic patients. BPRS
55  1999 No pharmacokinetic but pharmacodynamic interactions between cisapride and bromperidol or haloperidol. BPRS
56  1997 Single-dose pharmacokinetics and pharmacodynamics of oral triazolam in relation to cytochrome P4502C19 (CYP2C19) activity. CYP2C19, CYP3A4, EMs, PMs